Details
Stereochemistry | RACEMIC |
Molecular Formula | C11H13NO3.ClH |
Molecular Weight | 243.687 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CNC(C)C(=O)C1=CC=C2OCOC2=C1
InChI
InChIKey=GASYWEXOTOXXLK-UHFFFAOYSA-N
InChI=1S/C11H13NO3.ClH/c1-7(12-2)11(13)8-3-4-9-10(5-8)15-6-14-9;/h3-5,7,12H,6H2,1-2H3;1H
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C11H13NO3 |
Molecular Weight | 207.2258 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Methylone (3, 4-Methylenedioxy-N-methylcathinone), a β-keto analog of 3,4-methylenedioxy-N-methylamphetamine (MDMA) is a stimulant and psychoactive drug. Methylone is a popular drug of abuse that strongly increases the release of the three monoamines: dopamine, serotonin (5-HT) and norepinephrine. In addition, methylone inhibits plasma membrane catecholamine transporters but only weakly inhibit the vesicle transporter. In April 2013, methylone was listed in the Schedule 1 substance under the Controlled Substances Act.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Methylone and mCPP, two new drugs of abuse? | 2005 Dec |
|
Metabolism of the recently encountered designer drug, methylone, in humans and rats. | 2006 Aug |
|
The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. | 2007 Mar 22 |
|
[Analysis of designer drugs detected in the products purchased in fiscal year 2006]. | 2008 Oct |
|
Cytotoxic effects of 3,4-methylenedioxy-N-alkylamphetamines, MDMA and its analogues, on isolated rat hepatocytes. | 2009 Jan |
|
Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry. | 2010 Jun |
|
Metabolism of designer drugs of abuse: an updated review. | 2010 Jun 1 |
|
Head shop compound abuse amongst attendees of the Drug Treatment Centre Board. | 2010 May |
|
Modulation of human GABAA receptor function: a novel mode of action of drugs of abuse. | 2011 Dec |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 01:19:32 GMT 2023
by
admin
on
Sat Dec 16 01:19:32 GMT 2023
|
Record UNII |
D930G9LZ75
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
D930G9LZ75
Created by
admin on Sat Dec 16 01:19:32 GMT 2023 , Edited by admin on Sat Dec 16 01:19:32 GMT 2023
|
PRIMARY | |||
|
186028-80-8
Created by
admin on Sat Dec 16 01:19:32 GMT 2023 , Edited by admin on Sat Dec 16 01:19:32 GMT 2023
|
PRIMARY | |||
|
46738160
Created by
admin on Sat Dec 16 01:19:32 GMT 2023 , Edited by admin on Sat Dec 16 01:19:32 GMT 2023
|
PRIMARY | |||
|
DTXSID40940032
Created by
admin on Sat Dec 16 01:19:32 GMT 2023 , Edited by admin on Sat Dec 16 01:19:32 GMT 2023
|
PRIMARY | |||
|
7540
Created by
admin on Sat Dec 16 01:19:32 GMT 2023 , Edited by admin on Sat Dec 16 01:19:32 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
|